Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2025 05:00 ET | Source: Osivax

Osivax Announces First Participant Vaccinated in Phase 2b Trial Evaluating Broad-Spectrum Influenza A Vaccine Candidate, OVX836

Phase 2b to assess efficacy, safety, and immunogenicity2,850 participants to be enrolled across European countries Lyon, France and Liège, Belgium – September 16, 2025 – Osivax, a biopharmaceutical...
September 12, 2025 17:33 ET | Source: ThinkCareBelieve

ThinkCareBelieve: Week 34 of the Trump Administration

Washington, DC, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/09/12/week-34-of-the-trump-administration/ ThinkCareBelieve has...
August 30, 2025 18:33 ET | Source: ThinkCareBelieve

ThinkCareBelieve: Week 32 of America and Trump 2.0

Washington, DC, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/08/30/week-32-of-america-and-trump-2-0/ There has not been one dull...
August 28, 2025 09:00 ET | Source: Hannaford Bros. Co., LLC

Annual flu shots now available at Hannaford pharmacies

Hannaford is now offering flu shots at its in-store pharmacies in Maine, New Hampshire, New York, Massachusetts and Vermont.
August 26, 2025 05:00 ET | Source: Osivax

Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness

Funding to accelerate development of Osivax’ broad-spectrum influenza A vaccine candidate, OVX836 Lyon, France and Liège, Belgium – August 26, 2025 – Osivax, a biopharmaceutical company developing...
August 06, 2025 16:05 ET | Source: HilleVax, Inc.

HilleVax Reports Second Quarter 2025 Financial Results

BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial...
August 04, 2025 07:00 ET | Source: HilleVax, Inc.

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

BOSTON, Mass., and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (“HilleVax” or “the Company”) (NASDAQ: HLVX) and XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA)...
July 28, 2025 09:30 ET | Source: Unity Consortium

Unity Consortium Announces Publication of Journal of Adolescent Health Supplement: “Expert Perspectives on Evolving Adolescent Well Visits and Immunization Platforms”

A new Journal supplement explores the evolution, impact, and future of adolescent well visits and immunization platforms in improving teen health.
July 16, 2025 10:00 ET | Source: Global Virus Network

A Statement from the Global Virus Network (GVN) on the Rapidly Escalating Measles Crisis in the U.S. and Worldwide

GVN is sounding the alarm over a sharp resurgence of measles cases in the United States and globally.
July 10, 2025 05:00 ET | Source: Osivax

Osivax Publishes Phase 2a Results Supporting Co-Administration of OVX836 with Seasonal Flu Vaccine in Vaccines Journal

Co-administration of OVX836 with seasonal inactivated influenza vaccine (Fluarix® Tetra) was well-tolerated and demonstrated a favorable safety profileRobust complementary immune responses were...